论文部分内容阅读
目的:探讨癌症患者在接受癌症药物治疗过程中心血管并发症的发生情况。方法:选择癌症患者80例,将其随机分为两组,对照组40例采用常规治疗,观察组40例采用抗肿瘤抗生素治疗,就常规治疗和抗肿瘤抗生素治疗进行回顾性分析。结果:观察组40例中,有心血管并发症的有30例,有其他并发症的有5例,没有并发症的有5例,心血管并发症发生率为75.0%。对照组40例中有心血管并发症的有20例,有其他并发症的有10例,没有并发症的有10例,发生率为50.0%。观察组的心血管并发症发生率明显高于对照组,差异有统计学意义。观察组住院时间为(6±107)d,对照组为(6±155)d。结论:两种方法各有优缺点,应采取针对性的治疗,有效控制癌细胞的不断增殖,减少病毒载体,降低并发症的发生率,提高生存质量,提高临床疗效,具有非常重要的临床效果。
Objective: To investigate the incidence of cardiovascular complications in cancer patients receiving cancer drugs. Methods: Eighty cancer patients were selected and randomly divided into two groups. The control group was treated by conventional therapy. The observation group was treated by antitumor antibiotics and the conventional therapy and antitumor antibiotic therapy were retrospectively analyzed. Results: In the observation group of 40 cases, there were 30 cases of cardiovascular complications, 5 cases of other complications, 5 cases of no complications, and the incidence of cardiovascular complications was 75.0%. Control group, 40 cases of cardiovascular complications in 20 cases, 10 cases of other complications, no complications in 10 cases, the incidence was 50.0%. The incidence of cardiovascular complications in the observation group was significantly higher than that in the control group, the difference was statistically significant. The length of stay in the observation group was (6 ± 107) days and in the control group was (6 ± 155) days. Conclusion: The two methods have their own advantages and disadvantages, we should take targeted treatment, effective control of the proliferation of cancer cells, reducing the viral vector, reducing the incidence of complications, improve quality of life and improve clinical efficacy, has a very important clinical effect .